Cargando…

Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()

OBJECTIVE: The objective was to address bias in contraception efficacy studies through a randomized study trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) and a levonorgestrel (LNG) implant. STUDY DESIGN: We analyzed data from the Evidence for C...

Descripción completa

Detalles Bibliográficos
Autores principales: Onono, Maricianah, Nanda, Kavita, Heller, Kate B., Taylor, Doug, Yacobson, Irina, Heffron, Renee, Kasaro, Margaret Phiri, Louw, Cheryl E., Nhlabasti, Zelda, Palanee-Phillips, Thesla, Smit, Jenni, Wakhungu, Imelda, Gichangi, Peter B., Mugo, Nelly R., Morrison, Charles, Baeten, Jared M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301167/
https://www.ncbi.nlm.nih.gov/pubmed/32577615
http://dx.doi.org/10.1016/j.conx.2020.100026
_version_ 1783547636889944064
author Onono, Maricianah
Nanda, Kavita
Heller, Kate B.
Taylor, Doug
Yacobson, Irina
Heffron, Renee
Kasaro, Margaret Phiri
Louw, Cheryl E.
Nhlabasti, Zelda
Palanee-Phillips, Thesla
Smit, Jenni
Wakhungu, Imelda
Gichangi, Peter B.
Mugo, Nelly R.
Morrison, Charles
Baeten, Jared M.
author_facet Onono, Maricianah
Nanda, Kavita
Heller, Kate B.
Taylor, Doug
Yacobson, Irina
Heffron, Renee
Kasaro, Margaret Phiri
Louw, Cheryl E.
Nhlabasti, Zelda
Palanee-Phillips, Thesla
Smit, Jenni
Wakhungu, Imelda
Gichangi, Peter B.
Mugo, Nelly R.
Morrison, Charles
Baeten, Jared M.
author_sort Onono, Maricianah
collection PubMed
description OBJECTIVE: The objective was to address bias in contraception efficacy studies through a randomized study trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) and a levonorgestrel (LNG) implant. STUDY DESIGN: We analyzed data from the Evidence for Contraceptive Options and HIV Outcomes Trial, which assessed HIV incidence among 7829 women from 12 sites in eSwatini, Kenya, South Africa and Zambia seeking effective contraception and who consented to be randomized to DMPA-IM, copper IUD or LNG implant. We used Cox proportional hazards regression adjusted for condom use to compare pregnancy incidence during both perfect and typical (i.e., allowing temporary interruptions) use. RESULTS: A total of 7710 women contributed to this analysis. Seventy pregnancies occurred during perfect and 85 during typical use. There was no statistically significant difference in perfect use pregnancy incidence among the methods: 0.61 per 100 woman-years for DMPA-IM [95% confidence interval (CI) 0.36–0.96], 1.06 for copper IUD (95% CI 0.72–1.50) and 0.63 for LNG implants (95% CI 0.39–0.96). Typical use pregnancy rates were also largely similar: 0.87 per 100 woman-years for DMPA-IM (95% CI 0.58–1.25), 1.11 for copper IUD (95% CI 0.77–1.54) and 0.63 for LNG implants (95% CI 0.39–0.96). CONCLUSIONS: In this randomized trial of highly effective contraceptive methods among African women, both perfect and typical use resulted in low pregnancy rates. Our findings provide strong justification for improving access to a broader range of longer-acting contraceptive options including LNG implants and copper IUD for African women. IMPLICATIONS STATEMENT: Data from this study support recommendations to providers, policy makers and patients that all of these methods provide safe and highly effective contraception for African women.
format Online
Article
Text
id pubmed-7301167
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73011672020-06-22 Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()() Onono, Maricianah Nanda, Kavita Heller, Kate B. Taylor, Doug Yacobson, Irina Heffron, Renee Kasaro, Margaret Phiri Louw, Cheryl E. Nhlabasti, Zelda Palanee-Phillips, Thesla Smit, Jenni Wakhungu, Imelda Gichangi, Peter B. Mugo, Nelly R. Morrison, Charles Baeten, Jared M. Contracept X Article OBJECTIVE: The objective was to address bias in contraception efficacy studies through a randomized study trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) and a levonorgestrel (LNG) implant. STUDY DESIGN: We analyzed data from the Evidence for Contraceptive Options and HIV Outcomes Trial, which assessed HIV incidence among 7829 women from 12 sites in eSwatini, Kenya, South Africa and Zambia seeking effective contraception and who consented to be randomized to DMPA-IM, copper IUD or LNG implant. We used Cox proportional hazards regression adjusted for condom use to compare pregnancy incidence during both perfect and typical (i.e., allowing temporary interruptions) use. RESULTS: A total of 7710 women contributed to this analysis. Seventy pregnancies occurred during perfect and 85 during typical use. There was no statistically significant difference in perfect use pregnancy incidence among the methods: 0.61 per 100 woman-years for DMPA-IM [95% confidence interval (CI) 0.36–0.96], 1.06 for copper IUD (95% CI 0.72–1.50) and 0.63 for LNG implants (95% CI 0.39–0.96). Typical use pregnancy rates were also largely similar: 0.87 per 100 woman-years for DMPA-IM (95% CI 0.58–1.25), 1.11 for copper IUD (95% CI 0.77–1.54) and 0.63 for LNG implants (95% CI 0.39–0.96). CONCLUSIONS: In this randomized trial of highly effective contraceptive methods among African women, both perfect and typical use resulted in low pregnancy rates. Our findings provide strong justification for improving access to a broader range of longer-acting contraceptive options including LNG implants and copper IUD for African women. IMPLICATIONS STATEMENT: Data from this study support recommendations to providers, policy makers and patients that all of these methods provide safe and highly effective contraception for African women. Elsevier 2020-05-28 /pmc/articles/PMC7301167/ /pubmed/32577615 http://dx.doi.org/10.1016/j.conx.2020.100026 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Onono, Maricianah
Nanda, Kavita
Heller, Kate B.
Taylor, Doug
Yacobson, Irina
Heffron, Renee
Kasaro, Margaret Phiri
Louw, Cheryl E.
Nhlabasti, Zelda
Palanee-Phillips, Thesla
Smit, Jenni
Wakhungu, Imelda
Gichangi, Peter B.
Mugo, Nelly R.
Morrison, Charles
Baeten, Jared M.
Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()
title Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()
title_full Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()
title_fullStr Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()
title_full_unstemmed Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()
title_short Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception()()
title_sort comparison of pregnancy incidence among african women in a randomized trial of intramuscular depot medroxyprogesterone acetate (dmpa-im), a copper intrauterine device (iuds) or a levonorgestrel (lng) implant for contraception()()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301167/
https://www.ncbi.nlm.nih.gov/pubmed/32577615
http://dx.doi.org/10.1016/j.conx.2020.100026
work_keys_str_mv AT ononomaricianah comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT nandakavita comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT hellerkateb comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT taylordoug comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT yacobsonirina comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT heffronrenee comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT kasaromargaretphiri comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT louwcheryle comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT nhlabastizelda comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT palaneephillipsthesla comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT smitjenni comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT wakhunguimelda comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT gichangipeterb comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT mugonellyr comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT morrisoncharles comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT baetenjaredm comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception
AT comparisonofpregnancyincidenceamongafricanwomeninarandomizedtrialofintramusculardepotmedroxyprogesteroneacetatedmpaimacopperintrauterinedeviceiudsoralevonorgestrellngimplantforcontraception